176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-13.64%
Revenue decline while MRVL shows 11.56% growth. Joel Greenblatt would examine competitive position erosion.
-9.49%
Cost reduction while MRVL shows 8.27% growth. Joel Greenblatt would examine competitive advantage.
-21.56%
Gross profit decline while MRVL shows 14.43% growth. Joel Greenblatt would examine competitive position.
-9.16%
Margin decline while MRVL shows 2.58% expansion. Joel Greenblatt would examine competitive position.
3.38%
R&D growth less than half of MRVL's 9.23%. David Dodd would verify if efficiency advantage is sustainable.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
10.60%
Operating expenses growth while MRVL reduces costs. John Neff would investigate differences.
-4.92%
Both companies reducing total costs. Martin Whitman would check industry trends.
No Data
No Data available this quarter, please select a different quarter.
5.33%
D&A growth while MRVL reduces D&A. John Neff would investigate differences.
-69.32%
EBITDA decline while MRVL shows 13.57% growth. Joel Greenblatt would examine position.
-42.96%
EBITDA margin decline while MRVL shows 1.80% growth. Joel Greenblatt would examine position.
-62.75%
Operating income decline while MRVL shows 127.66% growth. Joel Greenblatt would examine position.
-56.87%
Operating margin decline while MRVL shows 124.79% growth. Joel Greenblatt would examine position.
-8.28%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
-61.23%
Pre-tax income decline while MRVL shows 135.83% growth. Joel Greenblatt would examine position.
-55.11%
Pre-tax margin decline while MRVL shows 132.12% growth. Joel Greenblatt would examine position.
-61.23%
Tax expense reduction while MRVL shows 20.69% growth. Joel Greenblatt would examine advantage.
-61.23%
Net income decline while MRVL shows 117.98% growth. Joel Greenblatt would examine position.
-55.11%
Net margin decline while MRVL shows 116.12% growth. Joel Greenblatt would examine position.
-60.00%
EPS decline while MRVL shows 119.69% growth. Joel Greenblatt would examine position.
-60.00%
Diluted EPS decline while MRVL shows 114.76% growth. Joel Greenblatt would examine position.
-5.32%
Share count reduction while MRVL shows 1.76% change. Joel Greenblatt would examine strategy.
0.23%
Diluted share reduction exceeding 1.5x MRVL's 8.67%. David Dodd would verify capital allocation.